BriaCell Therapeutics Corp. (BCTXW) 是一家上市公司 属于 医疗保健 板块，经营于 生物科技 行业. 公司总部位于 West Vancouver, BC, 加拿大. 现任CEO为 William V. Williams.
BCTXW 拥有 IPO日期为 2012-08-13, 16 名全职员工, 在 NASDAQ Capital Marke, 市值为 $1.7K.
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
